this GLP-1 weight loss medication Weight Loss Treatment

Medically-Supervised Weight Loss Treatment Plan in Ottawa

What is our weight loss program®?

this GLP-1 weight loss medication is a prescription medication that contains semaglutide, a GLP-1 receptor agonist approved for chronic weight management.

this GLP-1 weight loss medication works by:

• Reducing appetite signals in the brain
• Slowing stomach emptying
• Increasing feelings of fullness after meals

It is typically administered as a regular injection and should be used alongside lifestyle changes such as improved nutrition and physical activity.

Medical assessment is required to determine whether this GLP-1 weight loss medication is appropriate for a patient.

How our weight loss program® Works for Weight Loss

this GLP-1 weight loss medication targets hormones that control hunger and satiety. Patients often experience:

• Reduced calorie intake due to decreased appetite
• Improved portion control
• Support for sustainable weight loss

Clinical studies show that semaglutide medications, when combined with lifestyle modifications, can produce meaningful reductions in body weight over time.

this GLP-1 weight loss medication vs Ozempic

Ozempic and weight loss medication contain the same active ingredient, semaglutide, but are approved for different purposes:

• Ozempic: Approved primarily for type 2 diabetes management
• GLP-1 weight loss medication: Approved specifically for chronic weight management

Dosing schedules differ. At Inovo Medical, treatment plans are based on a medical assessment to determine whether prescription therapy is appropriate. When clinically indicated, prescriptions are provided for our weight loss program as part of the weight management program. Ozempic is not offered as part of this program.

Our this GLP-1 weight loss medication Weight Loss Program

The Inovo Medical this GLP-1 weight loss medication program provides physician supervised medical weight management.

Program features include:

• Physician consultation and prescription
• Guidance on lifestyle adjustments and dosing
• Access to body contouring technologies during the program

Patients enrolled in the program may receive 50% off TruSculpt and TruFlex treatments during the twelve-month program period. These treatments may help support body composition and muscle tone during weight loss.

What Does It Cost?

The this GLP-1 weight loss medication program is $3,250 plus HST.

Medication costs are separate and depend on pharmacy pricing and insurance coverage.

Patients should confirm medication coverage directly with their insurance provider.

IMPORTANT NOTE: this GLP-1 weight loss medication is a prescription medication that may also be prescribed by a family physician or another healthcare provider. Patients who have access to a family doctor may wish to discuss the medication with their physician before enrolling in a clinic program.

The Inovo Medical program is intended for individuals seeking structured medical oversight and access to additional body contouring treatments during their weight management process.

Who May Be a Candidate For this GLP-1 weight loss medication

this GLP-1 weight loss medication may be appropriate for adults who meet medical criteria for weight management treatment.

Patients often consider treatment when they:

• Have obesity or excess body weight
• Have difficulty losing weight through diet and exercise alone
• Experience persistent hunger or difficulty controlling food intake

Eligibility must be determined through medical assessment.

Not all patients are appropriate candidates for semaglutide treatment.

Expected Weight Loss Results with this GLP-1 weight loss medication

Weight loss outcomes vary between individuals.

Clinical studies involving semaglutide medications have shown meaningful reductions in body weight when the medication is used alongside nutrition changes and physical activity.

Results depend on several factors including:

• Starting body weight
• Treatment adherence
• Lifestyle habits
• Individual metabolic response

The objective of treatment is gradual, medically supervised weight reduction.